Abstract Prolyl oligopeptidase (POP) is a serine endopeptidase that hydrolyses proline-containing peptides shorter than 30-mer, including many bioactive peptides. The distribution of POP in the brain has been studied but little is known about the distribution of peripheral POP. We used immunohistochemistry to localize POP in mouse wholebody sections and at the cellular level in peripheral tissues. Furthermore, we used a POP activity assay to reveal the associations between POP protein and its enzymatic activity. The highest POP protein densities were found in brain, kidney, testis and thymus, but in the liver the amounts of POP protein were small. There were remarkable diVerences between the distribution of POP protein and activity. The highest POP activities were found in the liver and testis while kidney had the lowest activity. In peripheral tissues, POP was present in various cell types both in the cytoplasm and nucleus of the cells, in contrast to the brain where no nuclear localization was detected. These Wndings support the proposed role of POP in cell proliferation in peripheral tissues. The dissociation of the distribution of POP protein and its enzymatic activity points to nonhydrolytic functions of POP and to strict endogenous regulation of POP activity.
Introduction
Prolyl oligopeptidase (POP, prolyl endopeptidase, EC 3.4.21.26 ) is an 80 kDa enzyme that belongs to the POP family of serine proteases (family S9 of clan SC) which has an ancient origin (Rawlings and Barrett 1994; Venäläinen et al. 2004) . POP has been implicated in the hydrolysis of many proline-containing bioactive peptides such as angiotensins, arginine-vasopressin, substance P and thyrotropin releasing hormone (for reviews, see Polgar 1994; GarciaHorsman et al. 2007; Männistö et al. 2007 ). Several of these recognized POP substrates are known to be involved in the functions of the CNS, such as memory and learning (Huston and Hasenohrl 1995; Garcia-Horsman et al. 2007; Männistö et al. 2007 ). Furthermore, alterations in the plasma POP enzyme activity have been measured in several psychiatric diseases (Maes et al. 1994 (Maes et al. , 1995 (Maes et al. , 2001 ) and neurological diseases (Mantle et al. 1996) .
These Wndings have served as the rationale for developing POP enzyme inhibitors. Although the eVects of POP inhibitors to the neuropeptide levels in brains are still far from convincing Männistö et al. 2007 ) they have restored decreased neuropeptide levels in some studies (Toide et al. 1995b (Toide et al. , 1996 and prevented the cognitive symptoms induced by MPTP in monkeys or by scopolamine in rats (Toide et al. 1995a; Schneider et al. 2002) . Recently, several reports have provided evidence that POP may be involved in IP 3 signaling in the brain (Schulz et al. 2002; Williams et al. 2002; Cheng et al. 2005) and suggested that the enzyme may be a possible target of mood stabilizing drugs (Cheng et al. 2005) .
In human and rat tissues, POP enzyme activities have been localized widely in diVerent organs (Kato et al. 1980; Daly et al. 1985; Fuse et al. 1990; Goossens et al. 1996; Agirregoitia et al. 2005 ) and high activities have been measured in the brain (Kato et al. 1980; Fuse et al. 1990; Irazusta et al. 2002; Agirregoitia et al. 2005) . POP-like activity has also been detected in body Xuids (Goossens et al. 1996) and in synaptosomal membranes (O'Leary and O'Connor 1995) . In the brain, the distribution of the immunoreactive POP protein (Myöhänen et al. 2007 ) was partially separated from the locations of enzyme activities or POP mRNA levels (Bellemere et al. 2004 ), pointing to endogenous and post-translational regulation of POP.
Prolyl oligopeptidase enzyme activities have been previously measured from some peripheral tissues such as skeletal muscle (Daly et al. 1985; Fuse et al. 1990 ), testis, liver, kidney, lung, renal cortex and gut (Fuse et al. 1990; Goossens et al. 1996; Agirregoitia et al. 2005) . However, the physiological function of POP in peripheral tissues has remained a mystery. Agirregoitia et al. (2007) reported that POP activity Xuctuates in the brain and also in several peripheral tissues during the embryonic and early development, suggesting that POP is involved in the phylogenesis. Furthermore, it has been proposed that POP may take part in DNA synthesis (Ohtsuki et al. 1994 (Ohtsuki et al. , 1997 Ishino et al. 1998 ). There may be involvement of POP in the proliferation and diVerentiation of liver cells (Matsubara et al. 1998) . However, POP is generally thought to be a cytosolic enzyme (Dresdner et al. 1982; Polgar 1994) , and immunohistochemical studies of cellular and subcellular POP brain distribution failed to detect any evidence of a nuclear location in the rat brain (Myöhänen et al. 2008b) . Therefore, the direct participation of POP in DNA synthesis and cell proliferation in the CNS seems debatable.
The present study was undertaken to localize and quantify POP protein at the macroscopic level in the mouse wholebody sections by immunohistochemistry using a speciWc POP antibody. Since this is a direct method, it is possible to determine the actual locations of the protein and compare the amounts of protein between the brain and peripheral tissues. We also measured POP enzyme activities in the same organs. Furthermore, immunohistochemistry and double-labeled immunoXuorescence were used to clarify the cellular distribution of POP in various organs. We also studied the distribution of POP between nucleus and cytoplasm using western blot-assay. Moreover, the possible involvement of POP in the cell cycle was studied using triple-labeled immunoXuorescence between POP, nucleus marker (DAPI) and a cell proliferation marker (Ki-67; Scholzen and Gerdes 2000) .
Materials and methods

Chemicals
The chemicals used were purchased from Sigma-Aldrich (St Louis, MO, USA) unless otherwise speciWed. NaCl was from FF-Chemicals AB (Yli-Ii, Finland) and ethanol from Altia (Helsinki, Finland).
Animals and tissue preparation
Six-to 8-week-old male NMRI mice (n = 20; eight for the whole-body immunohistochemistry, four for the paraYnembedded tissue samples and eight for the western blotting and enzyme activity measurements) were supplied by the National Laboratory Animal Center, University of Helsinki). Room temperature was 22°C and light/dark cycle 12 h/12 h. Animals had free access to food and water. For whole-body immunohistochemistry, mice were deeply anesthetized using chloral hydrate (450 mg/kg intraperitoneally, i.p.) and then perfused with saline for 10 min to reduce the possible background caused by POP in the plasma. After perfusion animals were quickly placed into isopentane cooled with dry ice (approximately ¡50°C for 30 s and then stored at ¡70°C until sectioning. Frozen animal was cryosectioned using a heavy-duty cryomicrotome (LKB 2250, LKB, Stockholm, Sweden) into 100 m sagittal sections, which were transferred to the gelatinized glass plates as previously described (Ullberg and Larsson 1981; Kawamoto and Shimizu 1986; Holmbom et al. 1991) .
For tissue sampling to the paraYn-embedded tissues, animals were deeply anesthetized using chloral hydrate (450 mg/kg i.p.) and then perfused with 4% paraformaldehyde solution. After perfusion, the internal organs were removed and placed in 10% paraformaldehyde solution until paraYn embedding and sectioning into 5 m paraYnembedded sections using a sliding microtome (Leica SM2000R, Leica Microsystems Inc., Wetzlar, Germany).
For enzyme activity measurements, tissues were removed, quickly frozen in liquid nitrogen and thereafter stored at ¡70°C until homogenized in Wve volumes of assay buVer (0.1 M Na-K-phosphate buVer, pH 7.0). The homogenate was centrifuged at 16,000g, 4°C, for 20 min. Aliquots of supernatant were frozen and stored at ¡70°C.
All animal procedures were conducted according to the Council of Europe (directive 86/609) and Finnish guidelines, and approved by the local animal ethics committee and State Provincial OYce of Eastern Finland.
Preparation of polyclonal POP antibody
The polyclonal POP antibody was prepared as described earlier (Venäläinen et al. 2006; Myöhänen et al. 2007 ). BrieXy, puriWed E. coli expressing recombinant human POP (for details of expression and puriWcation, see (Venäläinen et al. 2002) was used to generate antibodies against POP in a hen. Egg yolks were collected and IgY's were isolated by the water dilution method (Kokko et al. 1994 ) and POP-speciWc IgY was then puriWed by aYnity chromatography using a HiTrap NHS column coupled with puriWed POP as reported (Venäläinen et al. 2006) .
Antibody speciWcity in mouse tissues was assayed by western blotting using mouse tissue homogenates from the whole brain, liver, kidney and testis while puriWed recombinant pig POP served as a control. In all experiments, only one band at around 80 kDa, corresponding to the full length POP, was detected (Fig. 1) . We also studied whether antibody was able to react with human dipeptidyl peptidase IV (DPPIV, EC 3.4.14.5, a gift from GlaxoSmithKline), the closest relative of POP (Venäläinen et al. 2004 ). Amounts as high as 2.5 g of pure DPPIV did not react with the anti-POP IgY in western blot experiments (data not shown). In addition, a preabsorption control was conducted with POP protein (see below) with negative Wndings.
Light microscopic immunohistochemistry
Immunohistochemistry for whole-body sections was performed by modifying our method for frozen brain sections (Myöhänen et al. 2007 ). In brief, sections were treated with 0.1% NaN 3 and 0.3% H 2 O 2 in phosphate buVered saline (PBS) for 10 min to block the endogenous peroxidase. Then, sections were incubated in blocking solution (10% BSA in PBS) for 40 min. Primary antibody against POP (solution 1:1,000 in 3% BSA in PBS) were added and the sections were incubated for 48 h at +4°C. After the primary antibody incubation, there was 2 h incubation in room temperature with peroxidase conjugated rabbit anti-chicken IgY secondary antibody solution (Product #31401, Pierce Biotechnology, Rockford, IL, USA, solution 1/1,000 in 3% BSA in PBS). Immunocomplexes were detected by using DAB with a nickel enhancer.
For paraYn-embedded mouse tissues, immunohistochemistry was performed using the following protocol. Sections were dewaxed in xylene, rehydrated with graded alcohols and washed with 0.1 M PBS. The antigen retrieval was processed in a microwave oven in citrate buVer (pH 6.0) for 3 £ 5 min. Endogenous peroxidase activity was inactivated with 5% hydrogen peroxide containing 0.1% NaN 3 for 5 min, and nonspeciWc binding was blocked with 5% normal goat serum (Chemicon International Inc., Temencula, CA, USA) in PBS. The slides were incubated overnight at 4°C with POP-antibody (dilution 1:1,000 in 1% goat normal serum), followed by washing with PBS. The slides were then incubated with the rabbit anti-chicken IgY HRP-conjugated secondary antibody (dilution 1:1,000 in 1% goat normal serum; Product #31401, Pierce Biotechnology, Rockford, IL, USA) for 60 min at room temperature, after which the slides were washed with PBS for 3 £ 5 min. The brown color was developed with 0.05% DAB and 0.03% hydrogen peroxide in PBS. Finally the slides were counterstained with Mayer's hematoxylin, washed, dehydrated and mounted with Depex (BDH, Poole, UK).
Control stainings for immunohistochemistry were carried out with the omission of the primary antibodies and with preadsorption control (see Wgures and details in Myöhänen et al. 2008b) . No evidence of any staining was observed in these controls.
Immunohistochemical stainings of whole-body section photomicrographs were captured using ImageQuant ECL RT imaging device (GE Healthcare, Buckinghamshire, UK) and paraYn embedded tissue samples were photographed with a digital camera connected to a Olympus BX40 microscope and DP50 imaging device (Olympus Corporation, Tokyo, Japan). A total number of six to ten paraYn-embedded sections of each organ/animal from two to four diVerent immunostainings was used in microscopic analysis.
Whole-body section Wgures were diverted from grayscale images to color coded images with Scion Image software (version alpha 4.0.3.2, Scion Corporation. Frederick, MD, USA). Only minor corrections to brightness and contrast and pixel errors were made with Adobe Photoshop CS2 (version 9.0, Adobe Systems Incorporated, San Jose, CA, USA). For tissue samples, only minor corrections to brightness and contrast were made with Adobe Photoshop CS2 software (version 9.0, Adobe Systems Incorporated).
ImmunoXuorescence microscopy
ImmunoXuorescence was performed similar as described before (Myöhänen et al. 2008b) . In brief, when studying the colocalization of POP with nucleus, a double-labeling immunoXuorescence technique was used. ParaYn-embedded sections were dewaxed as described above followed with 30 min incubation with 5% goat normal serum (Chemicon International Inc.). Thereafter, the sections were Fig. 1 The speciWcity of POP antibody in the mouse tissues was proven by western blot. We used homogenates from the whole brain, liver, kidney and testis while puriWed recombinant pig POP served as a control. Only one band at around 80 kDa, was detected incubated for overnight at +4°C with POP-antibody (dilution 1:500). After the PBS washes, POP-immunocomplexes were detected using rabbit anti-chicken IgY with Xuorescein conjugate (dilution 1:500; Product #31501, Pierce Biotechnology) as the secondary antibody. Vectashield with DAPI (Vector Laboratories, Burlingame, CA, USA) was used as a mounting medium to counterstain the nuclei of the cells.
In the triple-label immunoXuorescence, a slightly modiWed double-label technique was used. ParaYn-embedded sections were dewaxed and incubated in blocking solution (5% goat normal serum, Chemicon International Inc.) for 30 min followed by monoclonal rat anti-mouse IgG Ki-67 antibody (clone TEC-3; dilution 1:50; Dako, Glostrub, Denmark) incubation overnight at +4°C. After PBS washes, sections were incubated with Alexa Fluor 568 conjugated secondary antibody (goat anti-mouse IgG; dilution 1:200; Product # A11004, Molecular Probes/Invitrogen Corp., Eugene, OR, USA) for 30 min. ImmunoXuorescence with POP-antibody followed after PBS washes. The procedure was similar with the Wrst staining and 30 min incubation with blocking solution was used to minimize cross-reactions between antibodies. POPimmunocomplexes were detected using Xuorescent-conjugated secondary antibody as described above. Vectashield with DAPI (Vector Laboratories, Burlingame, CA, USA) was used as a mounting medium to counterstain the nuclei. Control stainings for immunoXuorescence were carried out with the omission of the primary antibodies. No evidence of any staining was observed in these negative controls (data not shown).
ImmunoXuorescence photomicrographs were captured by a digital camera connected to the Olympus BX40 microscope and DP50 imaging device (Olympus Corporation, Tokyo, Japan) and only corrections to brightness and contrast were made with Adobe Photoshop CS2 software (version 9.0, Adobe Systems Incorporated).
The percentages of colocalizations in double-and triplelabeling immunoXuorescence were calculated from urinary bladder, lungs and testis by comparing colocalized neurons with POP containing neurons and using Abercrombie's correction (Abercrombie and Johnson 1946) . In order to get suYcient number of cells to the calculations, all the cells in given cell group (photomicrograph) with clear-cut nuclei were counted (described in Myöhänen et al. 2008a, b) . The colocalization percentage for each area was calculated from and two to four diVerent immunostainings from four separate animals. The number of counted cells per organ was 28 § 2 (mean § SEM) and number of counted slides for each area varied from three to Wve.
Laser scanning microscopy Fluorescent double-labeled sections were analyzed and photographed using an Ultra VIEW Confocal Imaging System (PerkinElmer, Cambridge, UK) equipped with an argon-krypton laser mounted on an inverted Nikon Eclipse TE300 microscope (Nikon Corporation, Tokyo, Japan).
After capturing the images with an imaging device, confocal double-labeled immunoXuorescence micrographs were converted from grayscale images to RGB images and colorized with the corresponding colors (green and red) using Adobe Photoshop CS2 software (version 9.0, Adobe Systems Incorporated). Only minor corrections to brightness and contrast in the pictures were made.
Tissue fractioning and western blot analysis NE-PER Nuclear and Cytoplasmic Extraction Reagents (Product #78833, Pierce Biotechnology) was used to extract nuclear and cytoplasmic fractions from the brain, liver, kidney and testis. The tissues were cut in approximately 50 mg pieces and homogenized in cytoplasmic reagent with EDTA-free Halt protease inhibitor cocktail (Product #78410, Pierce Biotechnology). After homogenization, secondary cytoplasmic reagent was added and the fraction was centrifuged for 5 min at 16,000g. Immediately after centrifuging, supernatant (cytoplasmic fraction) was removed and stored at ¡80°C until use. The remaining pellet was washed twice using PBS and thereafter resuspended in the nuclear reagent, incubated for 40 min in ice and then centrifuged for 10 min at 16,000g. Supernatant (nuclear fraction) was removed and stored at ¡80°C until use.
The purity of nuclear and cytoplasmic fractions was conWrmed by western blot using anti-histone H3 goat anti-rabbit polyclonal antibody (nuclear marker, dilution 1:5,000, Product #H0164, Sigma-Aldrich) and anti-tubulin monoclonal antibody (cytoplasmic marker, dilution 1:5,000, Product #05-829, clone DM1A, Upstate, Temecula, CA, USA). In all western blot analyses, standard SDS-PAGE, transfer and blocking techniques were used and chemiluminescence images were captured using ImageQuant ECL RT imaging device (GE Healthcare, Buckinghamshire, UK).
The distribution of POP between nuclear and cytoplasmic fractions of the brain and peripheral tissues was assayed by western blot analysis using anti-POP (described above, dilution 1:5,000) as Wrst antibody, and goat anti-chicken IgY-HRP conjugate (dilution 1:10,000, Product #31401, Pierce Biotechnology) as a second reporter antibody.
Enzyme activity assay
The POP activity assay was performed as described earlier (Venäläinen et al. 2002) . BrieXy, an enzyme solution (10 l of tissue homogenates) was preincubated with 465 l of assay buVer for 30 min at 30°C. The reaction was initiated by adding 25 l of substrate (4 mM Suc-Gly-Pro-AMC) and the plates were incubated for 60 min at 30°C. The reaction was terminated by the addition of 500 l of 1 M sodium acetate buVer (pH 4.2). The formation of AMC was measured Xuorometrically using a The Wallac 1420 VIC-TOR Xuorescence plate reader (PerkinElmer, Waltham, MA, USA). The excitation and emission wavelengths were 360 and 460 nm, respectively. The protein concentration in the enzyme preparation was determined with Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA) based on the method of Bradford (1976) with bovine serum albumin as the standard.
The means of enzyme activity values for each organ of eight mice were calculated from the mean values of three to four diVerent assays.
Semiquantitative analysis
After capturing the photomicrographs of the whole-body sections, the images were analyzed using Bio-Rad QuantityOne 4.5.1 software (Bio-Rad Laboratories) as described earlier (Myöhänen et al. 2007 ). In the optical density (OD) analysis organs were delineated with the freehand-tool of the software. The background values of each organ (background obtained by control staining without primary antibody) were subtracted from raw data values of the same organ.
The OD values of diVerent brain areas were compared to the mean values of brain (set as a 100%), since the protein expression was highest in the brain. The averages and SEM of optical densities from each area were calculated using an Excel spreadsheet. The identiWcation and nomenclature of mouse internal organs was based to the atlas by Iwaki et al. (2001) . Eight organs from whole-body sections (adrenal glands were too small for this purpose) were analyzed and the results are shown in Fig. 2 . The total number of analyzed whole-body sections/animal was 20 § 2 (mean § SEM). Furthermore, the mean OD value of each organ was counted from 8 to 16 sections/animal.
Statistical analyses
Statistical analyses were performed using GraphPad Prism (version 4.03, GraphPad Software, Inc., San Diego, CA, USA). One-way ANOVA followed by Newman-Keuls multiple comparison test were performed to analyze the overall diVerences in OD-values and enzyme activities between organs. Statistically signiWcant diVerences were considered at P < 0.05.
Results
Whole-body immunohistochemistry
In mouse whole-body sections, POP protein was widely but unevenly distributed (Fig. 2) . The overall diVerences in the density of the POP protein between the organs were statistically signiWcant (one-way ANOVA, F 1,6 = 9.471; P < 0.0001). Moreover, liver and heart signiWcantly diVered from other organs (Newman-Keuls multiple comparison test, P < 0.05).
The highest amount of POP protein was observed in brain (Figs. 2, 3a, b) , but almost equally high levels of POP immunoreactivity was found in the kidney, testis and thymus (Figs. 2, 3a, b) . POP was also substantially present in the urinary bladder, lungs (Figs. 2, 3a, b) and heart. However, only a low amount of POP protein was detected in the liver (Figs. 2, 3a, b) .
Enzyme activity assay
In enzyme activity measurements (Fig. 2) , the highest POP activity was located in the liver followed by testis. The activity was moderate in the heart, lungs, thymus and brain. Smaller activities were measured from the urinary bladder, adrenal gland and kidney. Surprisingly, the lowest activities were assayed in the kidney although this organ contained almost the highest amount of POP protein, and a high activity was measured from liver regardless of its small protein amount. Moreover, the enzyme activity in the brain was only moderate despite the fact that it contained the highest protein amount. Generally, the POP enzyme activities in various organs diVered clearly from the POP protein distribution measured from the whole-body immunohistochemistry (Fig. 2) .
The overall diVerences in the POP enzyme activity between the organs were statistically signiWcant (one-way ANOVA, F 1,7 = 21.51; P < 0.0001). In enzyme activity Fig. 2 The distribution pattern of POP protein and enzyme activity in mouse peripheral tissues. The optical density (OD) values of POP protein in analyzed areas are compared to brain OD value (set as 100%). POP protein activity is presented in picomole of AMC/ minute £ milligram tissue. Asterisk: The OD value of adrenal gland was not analyzed due to its small size in whole-body sections assay, kidney, adrenal gland and urinary bladder signiWcantly diVered from other organs (Newman-Keuls multiple comparison test, P < 0.05).
Cellular distribution of POP in mouse tissues
Prolyl oligopeptidase was generally widely present in various cell types, both in their nuclei and cytoplasm. With respect to the liver, POP was moderately present in the cytoplasm and nucleus of the liver hepatocytes and nuclei of the KupVer's cells (Fig. 4a, b) . POP was also present in the hepatic endothelial cells (Fig. 4b) . In the lungs, a substantial amount of POP protein was observed both in type I and type II cells of the alveolar walls (Fig. 4c) . Substantial amount of POP protein was also found in the nuclei and cytoplasm of epithelial cells in the wall of the bronchioles (Fig. 4c) . In the lungs, POP protein was intensively present both in cytoplasm and nuclei of the cells (Fig. 4d-f) .
In kidney, high POP-immunoreactivity was observed in the medulla and it was less abundant in the cortex (Fig. 5a-c) . From moderate to high degree POP-immunoreactivity was present in the glomerular podocytes (Fig. 5b ) and the walls of tubules (Fig. 5a, b) , but only minor expression was found in the rest of the cortical labyrinth (Fig. 5a ). In medulla, POP was clearly present in the cells walls of tubules (Fig. 5c) In the adrenal glands, POP immunoreactivity was high both in the cortex and medulla (Fig. 5d-f ). In particular, the cells in the zona glomerulosa and zona reticularis were intensively immunostained (Fig. 5d, e) , while POP expression was slightly smaller in the zona fasciculata (Fig. 5d) . In the cortex, POP was preferentially present in the nuclei, whereas in the medullary chromaYn cells, POP was present both in the nuclei and cytoplasm (Fig. 5f ). In the heart, POP Fig. 3 a, b The color coded (from low levels = blue color or cooler to high levels = red tones or warmer) images of the distribution of POP in whole-body immunohistochemistry of mouse. B brain, G gastrointestinal tract, H heart, Li liver, Lu lungs, Ki kidney, ob olfactory bulb, skelm skeletal muscle, T testis, Th thymus, ub urinary bladder was moderately present in the nuclei and sarcomeres of the cardiac muscle (not shown).
In the testis, POP was amply present in the Leydig cells, myoWbroblasts of the lamina propria, Sertoli cells of seminiferous tubules, spermatogonia and spermatocytes (Fig. 6a, b) . Moderate POP immunoreactivity was seen in developing spermatids, but not in the mature spermatids (Fig. 6a, b) . In the testis, POP was most intensively stained in the nuclei (Fig. 6c-e) . Moderate amounts of POP protein were observed in the thymus, both in cortex and medulla. POP was also present in the nuclei of various types of epithelioreticular cells. POP was intensively present in the nuclei and cytosol of the epithelium cells of the urinary bladder ( Fig. 7a-e ) but preferably only in some cells. Moderate POP-immunoreactivity was seen in the connective tissue (Fig. 7a, b) but only sparse staining was found in the smooth muscle cells (Fig. 7a) .
Nuclear POP and cell proliferation
We used triple-label immunoXuorescence of POP, DAPI (a nuclear marker) and Ki-67 (a proliferation marker) to determine whether the presence of POP in the nuclei is associated with cell proliferation in peripheral cells. A rather poor colocalization (12 § 3%, average § SEM) between POP, DAPI and Ki-67 was seen, particularly in the urinary bladder epithelial cells (Fig. 8a-d) despite the abundant colocalization of POP and DAPI (Fig. 8a-g ). However, the colocalization was moderate between POP and Ki-67 (34 § 4% in urinary bladder), especially in the lungs (46 § 4%, Fig. 8e-g ), pointing to a possible role of POP in the cell proliferation. As a further support, similar results were calculated from testis where triple-label colocalization was 17 § 1% and colocalization between POP and Ki-67 was 39 § 8%.
Western blotting assay of nuclear and cytoplasmic POP A western blot analysis of POP protein was conducted from nuclear and cytosolic fractions of the brain, liver, kidney and testis. The conWrmation of the signiWcant nuclear localization of the POP protein was achieved in the peripheral tissues, in contrast to the brains, where no nuclear localization was seen (Fig. 9a) . The relative amounts of POP protein in the western blotting were roughly the same as the POP amounts in the immunohistochemistry. However, excluding the liver, the expression of POP protein was signiWcantly smaller in the nuclear than in the cytoplasmic fraction, indicating that POP is preferably present in the cytoplasm also in the peripheral tissues. The identity of nuclear and cytoplasmic fractions was conWrmed by nuclear (Histone H3) and cytoplasmic markers (tubulin) (Fig. 9b) .
Discussion
To the best of our knowledge, this is the Wrst time when the distribution of the POP protein has been quantitated in mouse whole-body sections and many mouse organs using immunohistochemistry. This is also the Wrst study where the POP protein has been detected in the nuclei of the cells of the peripheral tissues. Furthermore, we observed that the distribution of the POP protein and the enzymatic activity of POP are clearly diVerent, also in the peripheral tissues, similar to the situation in the brain (Myöhänen et al. 2007 ).
Our whole-body immunohistochemistry revealed that the POP protein is widely, but still speciWcally, distributed in peripheral tissues. Based on the enzyme activity studies (Daly et al. 1985; Fuse et al. 1990; Irazusta et al. 2002; Agirregoitia et al. 2005) , there has been a belief that the highest amounts of POP are located in the brain, although the studies have been somewhat inconsistent. The diVerences between these enzyme activity studies may arise from the use of diVerent species and substrates. We have now revealed that the POP protein is equally abundantly present in the mouse brain, kidney, testis and thymus, though much less in the liver. Interestingly, POP activity signiWcantly diVered from what would be expected based on the amount of the POP protein. Moreover, surprisingly, the activities of the POP in the testis and liver were signiWcantly higher than those in the brain.
This raises the interesting question about the regulation of POP activity. An endogenous inhibitor to the POP has been described (Salers 1994; Yamakawa et al. 1994) , although its function and mechanism are still poorly characterized. The uneven distribution of proposed POP substrates, e.g., substance P or angiotensins, in diVerent tissues only partially explains the distribution of POP protein (for review, see Harrison and Geppetti 2001; Severini et al. 2002; Almeida et al. 2004) . Furthermore, spatial colocalizations of POP protein and substance P are poor also in the rat brain (Myöhänen et al. 2008a) , indicating that at least some kind of transport system is needed to permit the hydrolysis of POP substrates-at least substance P-i.e., the locations of POP with its presumed substrates are not identical in vivo.
Prolyl oligopeptidase protein was present in various cell types in many diVerent organs, excluding the possibility of cell-type speciWcity. POP has been considered as a cytosolic enzyme but a membrane-bound form has been described (Dresdner et al. 1982; O'Leary and O'Connor 1995; Garcia-Horsman et al. 2007 ) and they both are present in the brain (Schulz et al. 2005; Myöhänen et al. 2008b) . Based on our immunohistochemical and western blot studies, it is concluded that POP is generally present also in the nuclei of the peripheral tissues. POP protein and In order to assure the presence of nuclear POP in peripheral tissues but not in the brain, western blot was performed using nuclear (n) and cytoplasmic (c) fractions from mouse brain, liver, kidney and testis. In brain nuclear fraction, no POP was detected but in the peripheral tissues, POP protein was present also in nucleus (a). The same amount of tissue homogenate (20 l) was used in both cytoplasmic and nuclear fractions. The purities of the fractions were conWrmed using speciWc cytosol marker (tubulin, upper image in b) and nuclear marker (histone H3, lower image in b) enzymatic activity have been detected in the nucleus of nonneuronal cell lines (Ishino et al. 1998) , as well as probably early in development also in neuronal cell cultures (M. J. Moreno-Baylach, J. Felipo, P. T. Männistö and J. A. Garcia-Horsman, unpublished results 2007) . This is in contrast to the brain where we were not able to detect any POP protein in the nuclei (this study; (Myöhänen et al. 2008b ). This Wnding may be signiWcant when deWning the physiological role of POP. These variations between the expression of POP in the brain, cell lines and peripheral tissues may reXect diVerences in cell proliferation. It is well known that the mature brain tissue is not proliferating, while peripheral tissues and cell lines are continuously dividing. Moreover, we observed that the POP protein was not present in all the nuclei of the same cell type. Therefore, we tested this hypothesis with Ki-67, which is expressed only in the proliferating cells, but not in the cells in the G0-phase (for review, see Scholzen and Gerdes 2000) . The nuclear colocalization of POP protein and Ki-67 was only partial but nonetheless the colocalization of non-nuclear POP and Ki-67 was rather convincing. Based on these results, the proposal that POP can directly aVect DNA synthesis in vitro (Ohtsuki et al. 1994 (Ohtsuki et al. , 1997 Ishino et al. 1998) remains unsolved. There is also appreciable POP activity early in development (Matsubara et al. 1998; Agirregoitia et al. 2003 Agirregoitia et al. , 2007 and in cancer cells (Goossens et al. 1996) pointing to some role in cell division and/or diVerentiation. Furthermore, high POP activities were seen in the testis where the POP protein was exclusively present in the developing spermatids, supporting the results obtained by Kimura et al. (2002) in mouse testis. However, the mechanism by which POP regulates DNA synthesis or the cell cycle remains unknown.
It is probable that the POP protein has properties beyond its hydrolyzing activity. Schulz et al. (2005) suggested that POP is involved in protein secretion and processing through the cytoskeletal tubulin. Consequently, in proliferating tissues, such as peripheral tissues and cell lines, POP may have noncatalytic (Schulz et al. 2005) or other catalytic activities, such as modiWcation of nuclear transport or it may function as prolyl cis-trans isomerase (Lu et al. 2007; Ikura et al. 2008) . Clearly more studies are needed to clarify the nuclear functions of the POP protein.
In conclusion, our study demonstrated that POP is widely but unevenly distributed in various tissues and cell types. We also found that POP protein is abundantly present not only in the brain, but also in the testis, kidney and thymus, and that the distribution of POP protein in peripheral tissues is signiWcantly diVerent from the POP enzyme activity. One novel discovery was that outside the CNS, POP is located also in the nuclei. Although the expression of POP protein in the nucleus is not clearly associated with the active phase of the cell cycle, our Wnding supports a nonhydrolytic role for POP, such as involvement in nuclear transport and cell proliferation.
